Increasing Availability of eTMF and Emergence of Covid-19 to Augment Growth of Electronic Trial Master File (eTMF) Market

 

Electronic Trial Master File (eTMF) Market

An electronic trial master file (eTMF) is simply a trial master document in electronic form. It is a content management system specifically designed for the pharmaceutical industry, offering a formalized way of organizing, tracking, and storing clinical trial data. Electronic trial documents are usually stored on computers within trial execution units, or TUAs. Most documents are filed in one of these units, with each having its own password and access code required to open it. In most cases, physicians only need to give their patients the TUA login information when filing a claim and then they are able to begin storing and tracking electronically stored patient medical records.

Market Dynamics

Increasing availability of eTMF is expected to propel growth of the electronic trial master file (eTMF) market. For instance, in January 2021, Bioclinica, an integrated solutions provider of clinical life science and technology expertise, added eTMF as part of its CTMS offering. Moreover, increasing adoption of eTMF is also expected to aid in growth of the market. For instance, in November 2020, BetterLife Pharma Inc., a biotech company, selected Florence Healthcare to provide its electronic Trial Master File (‘eTMF’) for the conduct of the AP-003, its COVID-19 inhalation therapeutic trial. Similarly, in June 2019, Celltrion Healthcare, a biopharmaceutical company, adopted Veeva Vault eTMF.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the electronic trial master file (eTMF) market. For instance, globally, as of 5:15pm CET, 14 February 2021, there have been 108,153,741 confirmed cases of COVID-19, including 2,381,295 deaths, as reported to the World Health Organization.      

Among regions, North America is expected to witness significant growth in the electronic trial master file (eTMF) market, owing to increasing adoption of eTMF in the region. For instance, in March 2019, PRC Clinical, a full-service CRO in the U.S., adopted Veeva Vault in order to expand its eTMF capabilities.

Competitive Analysis

Major players operating in the electronic trial master file (eTMF) market include, CareLex.org, Paragon Solutions, Phlexglobal Ltd, SAFE-BioPharma Association, SterlingBio, SureClinical, Montrium Inc., and Arivis AG, OASIS, Transperfect, Veeva Systems, Vertmarkets, Inc., Mastercontrol, Inc., Florence Healthcare, and Advanstar Communications, Inc.

Major players operating in the electronic trial master file (eTMF) market are focused on adopting partnership strategies to enhance their market share. For instance, in September 2020, Phlexglobal announced successful creation and implementation of the Global TMF Center of Excellence with partner PRA Health Sciences, a contract research organization.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

Increased Prevalence of Chronic Diseases and Stem Cell Therapy R&D to Drive Stem Cell Assay Market Growth